$MBLY

Canaccord cuts Mobileye stock price target on autonomy concerns

Canaccord reduced its price target for Mobileye (MBLY) to $11.00 from $12.00, citing industry challenges and competition. The stock is down 50% over the past year. Mobileye's Q3 2026 earnings missed expectations, with revenue at $492 million. Analysts have mixed views on the company's future prospects.

Original reporting
Published Oct 30, 2026, 8:53 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 8:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$MBLY
Bearish
high confidence
Mentioned
$MBLY
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MBLYBearishMed
01

Why it matters

The downgrade may trigger short‑term selling but long‑term fundamentals remain mixed.

02

Market read

Analyst target reduction is a fresh catalyst that could affect Mobileye's stock price and sector sentiment.

03

What to watch

Potential upside from upcoming partnerships and long‑term AI roadmap not reflected in the target.

Relevance 6/10Novelty 6/10Timing: today

Background

Canaccord's target cut follows Mobileye's Q3 2026 earnings miss and competitive pressures in autonomous driving.

Company-level read

Ticker impact

$MBLYBearishHigh confidence
Context

Canaccord lowered Mobileye's price target to $11 from $12, citing autonomy market concerns and recent Q3 earnings miss.

Expected impact

likely downward pressure as investors reassess valuation

Evidence & confidence

Target reduction and bearish commentary are fresh analyst actions that can prompt sell‑offs.

Market effects

Autonomous‑driving sector may face broader valuation scrutiny after the downgrade.

US tech equities could see modest pullback in related stocks.

Limited to firms tied to autonomous vehicle technology.

Counterpoint

Some investors may view the cut as an overreaction given Mobileye's core business strength.

Key entities

  • Mobileye N.V.

    Autonomous driving technology provider listed on NASDAQ.

  • Canaccord Genuity

    Equity research firm issuing the price‑target revision.

Related articles

$MBLYMed

Piper Sandler reiterates Mobileye stock rating at overweight

Piper Sandler maintained an Overweight rating and $12.00 price target for Mobileye (MBLY) after its Q3 results beat expectations. The company's 2026 guidance increased but less than anticipated. Mobileye's stock is down 51% year-over-year, trading at $6.41. Piper Sandler noted risks like Chinese competition but expects higher-value ADAS sales to benefit Mobileye's P&L starting 2027. TD Cowen downgraded MBLY to Hold with a $7.00 price target, citing delays and partner challenges.

$MBLYMed

TD Cowen downgrades Mobileye stock rating on delayed timelines

TD Cowen downgraded Mobileye (MBLY) to Hold from Buy, lowering its price target to $7.00. The firm cited delayed timelines and headwinds with Western partners. Mobileye's Q3 2026 earnings missed expectations, with adjusted EPS of $0.11 and revenue of $492 million, down 2% YoY. The stock is near its 52-week low of $6.37, down 50% over the past year.

$MBLYMed

Mobileye Global Inc. Q3 2026 Earnings Call Summary

Mobileye Global Inc. raised its 2026 revenue guidance to $2.008 billion, citing higher SuperVision deliveries. The company is transitioning to comprehensive ADAS systems and expects EyeQ ASPs to stabilize in 2027. Q3 saw $51 million in R&D incentives boosting margins to 18%. Management confirmed on-track production programs with Volkswagen and plans for 2027 robotaxi commercialization.